•
Dec 31, 2023

Quantum-Si Q4 2023 Earnings Report

Quantum-Si's revenue increased due to its controlled commercial launch of its Platinum instrument, while also reducing operating expenses and net loss compared to the same period last year.

Key Takeaways

Quantum-Si reported a revenue of $400,000 for Q4 2023 as they continued the controlled commercial launch of their Platinum instrument. The company's gross margin was 45%. They are finalizing commercial readiness and expect full commercial launch by the end of Q1 2024. The net loss decreased to $22.0 million, and total operating expenses decreased to $28.1 million.

Revenue was $400,000 due to the controlled commercial launch of the Platinum instrument.

Gross margin was 45% for the quarter.

The company is finalizing commercial readiness for a full commercial launch by the end of Q1 2024.

Launched version 2 of its sequencing kit in early February 2024 and has begun shipping to customers

Total Revenue
$400K
EPS
-$0.16
Previous year: -$0.17
-5.9%
Adjusted EBITDA
-$25.1M
Previous year: -$24.5M
+2.5%
Total Operating Expenses
$28.1M
Gross Profit
$178K
Cash and Equivalents
$134M
Previous year: $84.3M
+58.8%
Free Cash Flow
-$20.6M
Previous year: -$23.1M
-10.7%
Total Assets
$298M
Previous year: $391M
-23.8%

Quantum-Si

Quantum-Si

Forward Guidance

For the full year 2024, Quantum-Si expects revenue between $3.7 and $4.2 million and adjusted total operating expenses less than $103 million. Total cash usage is expected to be less than $100 million. The company anticipates its cash balance will provide a runway into 2026.

Positive Outlook

  • Revenue is expected to be between $3.7 and $4.2 million.
  • Adjusted total operating expenses are expected to be less than $103 million.
  • Total cash usage is expected to be less than $100 million.
  • Cash balance is expected to provide a runway into 2026.
  • Full commercial launch of the Platinum instrument by the end of Q1 2024.

Challenges Ahead

  • The company's expectations with respect to future performance and development and commercialization of products and services
  • The company’s ongoing leadership transitions
  • Changes in applicable laws or regulations
  • The ability of the Company to raise financing in the future
  • The success, cost and timing of the Company's product development and commercialization activities